AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 26-50/144
INTERLEUKIN-2 PRODUCTION BY CULTURED HUMAN GRANULOSA-CELLS
Authors: ORVIETO R GENAZZANI AR PETRAGLIA F SCHWARTZ A SHELEF M BENRAFAEL Z
Citation: R. Orvieto et al., INTERLEUKIN-2 PRODUCTION BY CULTURED HUMAN GRANULOSA-CELLS, International journal of fertility and women's medicine, 42(5), 1997, pp. 297-300
CLINICAL UTILITY OF ADJUVANT GROWTH-HORMONE IN THE TREATMENT OF PATIENTS WITH POLYCYSTIC OVARIES UNDERGOING IN-VITRO FERTILIZATION
Authors: ARTINI PG DEMICHEROUX AA TAPONECO F CELA V DAMBROGIO G GENAZZANI AR
Citation: Pg. Artini et al., CLINICAL UTILITY OF ADJUVANT GROWTH-HORMONE IN THE TREATMENT OF PATIENTS WITH POLYCYSTIC OVARIES UNDERGOING IN-VITRO FERTILIZATION, Journal of assisted reproduction and genetics, 14(1), 1997, pp. 4-7
P53 NUCLEAR ACCUMULATION IN PRENEOPLASTIC LESIONS AND STAGE-I UTERINEENDOMETRIOID ADENOCARCINOMA
Authors: BUTTITTA F MARCHETTI A ATHANASSIADOU S GADDUCCI A BELLINA S COSIO S MANCINI F GENAZZANI AR BEVILACQUA G
Citation: F. Buttitta et al., P53 NUCLEAR ACCUMULATION IN PRENEOPLASTIC LESIONS AND STAGE-I UTERINEENDOMETRIOID ADENOCARCINOMA, Oncology Reports, 4(2), 1997, pp. 315-318
BONE-DENSITY CHANGES IN POSTMENOPAUSAL WOMEN WITH THE ADMINISTRATION OF IPRIFLAVONE ALONE OR IN ASSOCIATION WITH LOW-DOSE ERT
Authors: DEALOYSIO D GAMBACCIANI M ALTIERI P CIAPONI M VENTURA V MURA M GENAZZANI AR BOTTIGLIONI F
Citation: D. Dealoysio et al., BONE-DENSITY CHANGES IN POSTMENOPAUSAL WOMEN WITH THE ADMINISTRATION OF IPRIFLAVONE ALONE OR IN ASSOCIATION WITH LOW-DOSE ERT, Gynecological endocrinology, 11(4), 1997, pp. 289-293
FERTILITY DRUGS AND OVARIAN-CANCER
Authors: ARTINI PG FASCIANI A CELA V BATTAGLIA C DEMICHEROUX AA DAMBROGIO G GENAZZANI AR
Citation: Pg. Artini et al., FERTILITY DRUGS AND OVARIAN-CANCER, Gynecological endocrinology, 11(1), 1997, pp. 59-68
HORMONAL REPLACEMENT THERAPY AFFECTS CALCITONIN-GENE-RELATED PEPTIDE AND ATRIAL-NATRIURETIC-PEPTIDE SECRETION IN POSTMENOPAUSAL WOMEN
Authors: SPINETTI A MARGUTTI A BERTOLINI S BERNARDI F BIFULCO G DEGLIUBERTI EC PETRAGLIA F GENAZZANI AR
Citation: A. Spinetti et al., HORMONAL REPLACEMENT THERAPY AFFECTS CALCITONIN-GENE-RELATED PEPTIDE AND ATRIAL-NATRIURETIC-PEPTIDE SECRETION IN POSTMENOPAUSAL WOMEN, European journal of endocrinology, 137(6), 1997, pp. 664-669
STEROID-HORMONES IN ENDOMETRIAL AND BREAST-CANCER - REVIEW
Authors: GADDUCCI A GENAZZANI AR
Citation: A. Gadducci et Ar. Genazzani, STEROID-HORMONES IN ENDOMETRIAL AND BREAST-CANCER - REVIEW, European journal of gynaecological oncology, 18(5), 1997, pp. 371-378
NEUROENDOCRINE EFFECTS OF DIFFERENT ESTRADIOL-PROGESTIN REGIMENS IN POSTMENOPAUSAL WOMEN
Authors: STOMATI M BERSI C RUBINO S PALUMBO M COMITINI G GENAZZANI AD SANTRE M PETRAGLIA F GENAZZANI AR
Citation: M. Stomati et al., NEUROENDOCRINE EFFECTS OF DIFFERENT ESTRADIOL-PROGESTIN REGIMENS IN POSTMENOPAUSAL WOMEN, Maturitas, 28(2), 1997, pp. 127-135
EFFECTS OF COMBINED LOW-DOSE OF THE ISOFLAVONE DERIVATIVE IPRIFLAVONEAND ESTROGEN REPLACEMENT ON BONE-MINERAL DENSITY AND METABOLISM IN POSTMENOPAUSAL WOMEN
Authors: GAMBACCIANI M CIAPONI M CAPPAGLI B PIAGGESI L GENAZZANI AR
Citation: M. Gambacciani et al., EFFECTS OF COMBINED LOW-DOSE OF THE ISOFLAVONE DERIVATIVE IPRIFLAVONEAND ESTROGEN REPLACEMENT ON BONE-MINERAL DENSITY AND METABOLISM IN POSTMENOPAUSAL WOMEN, Maturitas, 28(1), 1997, pp. 75-81
DIFFERENCE OF LH AND FSH SECRETORY CHARACTERISTICS AND DEGREE OF CONCORDANCE BETWEEN POSTMENOPAUSAL AND AGING WOMEN
Authors: GENAZZANI AD PETRAGLIA F SGARBI L MONTANINI V HARTMANN B SURICO N BIOLCATI A VOLPE A GENAZZANI AR
Citation: Ad. Genazzani et al., DIFFERENCE OF LH AND FSH SECRETORY CHARACTERISTICS AND DEGREE OF CONCORDANCE BETWEEN POSTMENOPAUSAL AND AGING WOMEN, Maturitas, 26(2), 1997, pp. 133-138
SERUM ASSAY OF SOLUBLE CD44 STANDARD (SCD44-ST), CD44 SPLICE VARIANT V5 (SCD44-V5), AND CD44 SPLICE VARIANT V6 (SCD44-V6) IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER
Authors: GADDUCCI A FERDEGHINI M FANUCCHI A ANNICCHIARICO C COSIO S PRONTERA C BIANCHI R GENAZZANI AR
Citation: A. Gadducci et al., SERUM ASSAY OF SOLUBLE CD44 STANDARD (SCD44-ST), CD44 SPLICE VARIANT V5 (SCD44-V5), AND CD44 SPLICE VARIANT V6 (SCD44-V6) IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER, Anticancer research, 17(6D), 1997, pp. 4463-4466
PLATINUM COMPOUNDS AND PACLITAXEL IN ADVANCED EPITHELIAL OVARIAN-CANCER
Authors: GADDUCCI A BRUNETTI I COSIO S GIANNESSI PG GENAZZANI AR CONTE P
Citation: A. Gadducci et al., PLATINUM COMPOUNDS AND PACLITAXEL IN ADVANCED EPITHELIAL OVARIAN-CANCER, Anticancer research, 17(6D), 1997, pp. 4703-4708
HORMONE REPLACEMENT THERAPY AND GYNECOLOGICAL CANCER
Authors: GADDUCCI A FANUCCHI A COSIO S GENAZZANI AR
Citation: A. Gadducci et al., HORMONE REPLACEMENT THERAPY AND GYNECOLOGICAL CANCER, Anticancer research, 17(5B), 1997, pp. 3793-3798
ENDOGENOUS ESTROGEN AND ACETYLCHOLINE-INDUCED VASODILATION IN NORMOTENSIVE WOMEN
Authors: PINTO S VIRDIS A GHIADONI L BERNINI G LOMBARDO M PETRAGLIA F GENAZZANI AR TADDEI S SALVETTI A
Citation: S. Pinto et al., ENDOGENOUS ESTROGEN AND ACETYLCHOLINE-INDUCED VASODILATION IN NORMOTENSIVE WOMEN, Hypertension, 29(1), 1997, pp. 268-273
IPRIFLAVONE PREVENTS THE LOSS OF BONE MASS IN PHARMACOLOGICAL MENOPAUSE INDUCED BY GNRH-AGONISTS
Authors: GAMBACCIANI M CAPPAGLI B PIAGGESI L CIAPONI M GENAZZANI AR
Citation: M. Gambacciani et al., IPRIFLAVONE PREVENTS THE LOSS OF BONE MASS IN PHARMACOLOGICAL MENOPAUSE INDUCED BY GNRH-AGONISTS, Calcified tissue international, 61, 1997, pp. 15-18
CORD PLASMA CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN (CRF-BP) IN TERM AND PRETERM LABOR
Authors: PETRAGLIA F FLORIO P SIMONCINI T WOODS RJ GIUNTINI A GREMIGNI R SERRA GB GENAZZANI AR LOWRY PJ
Citation: F. Petraglia et al., CORD PLASMA CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN (CRF-BP) IN TERM AND PRETERM LABOR, Placenta, 18(2-3), 1997, pp. 115-119
PREOPERATIVE D-DIMER PLASMA ASSAY IS NOT A PREDICTOR OF CLINICAL OUTCOME FOR PATIENTS WITH ADVANCED OVARIAN-CANCER
Authors: GADDUCCI A MARRAI R BAICCHI U FERDEGHINI M FANUCCHI A WEISS C GENAZZANI AR
Citation: A. Gadducci et al., PREOPERATIVE D-DIMER PLASMA ASSAY IS NOT A PREDICTOR OF CLINICAL OUTCOME FOR PATIENTS WITH ADVANCED OVARIAN-CANCER, Gynecologic oncology, 66(1), 1997, pp. 85-88
MIDDLE CEREBRAL-ARTERY VELOCIMETRY - DIFFERENT CLINICAL RELEVANCE DEPENDING ON UMBILICAL VELOCIMETRY
Authors: STRIGINI FAL DELUCA G LENCIONI G SCIDA P GIUSTI G GENAZZANI AR
Citation: Fal. Strigini et al., MIDDLE CEREBRAL-ARTERY VELOCIMETRY - DIFFERENT CLINICAL RELEVANCE DEPENDING ON UMBILICAL VELOCIMETRY, Obstetrics and gynecology, 90(6), 1997, pp. 953-957
HIGH-LEVELS OF FETAL MEMBRANE ACTIVIN BETA-A AND ACTIVIN RECEPTOR-IIBMESSENGER-RNAS AND AUGMENTED CONCENTRATION OF AMNIOTIC-FLUID ACTIVIN-A IN WOMEN IN TERM OR PRETERM LABOR
Authors: PETRAGLIA F DIBLASIO AM FLORIO P GALLO R GENAZZANI AR WOODRUFF TK VALE W
Citation: F. Petraglia et al., HIGH-LEVELS OF FETAL MEMBRANE ACTIVIN BETA-A AND ACTIVIN RECEPTOR-IIBMESSENGER-RNAS AND AUGMENTED CONCENTRATION OF AMNIOTIC-FLUID ACTIVIN-A IN WOMEN IN TERM OR PRETERM LABOR, Journal of Endocrinology, 154(1), 1997, pp. 95-101
CHANGES OF DIMERIC INHIBIN-B LEVELS IN MATERNAL SERUM THROUGHOUT HEALTHY GESTATION AND IN WOMEN WITH GESTATIONAL DISEASES
Authors: PETRAGLIA F LUISI S BENEDETTO C ZONCA M FLORIO P CASAROSA E VOLPE A BERNASCONI S GENAZZANI AR
Citation: F. Petraglia et al., CHANGES OF DIMERIC INHIBIN-B LEVELS IN MATERNAL SERUM THROUGHOUT HEALTHY GESTATION AND IN WOMEN WITH GESTATIONAL DISEASES, The Journal of clinical endocrinology and metabolism, 82(9), 1997, pp. 2991-2995
CHANGES IN AMNIOTIC-FLUID IMMUNOREACTIVE CORTICOTROPIN-RELEASING FACTOR (CRF) AND CRF-BINDING PROTEIN-LEVELS IN PREGNANT-WOMEN AT TERM AND DURING LABOR
Authors: FLORIO P WOODS RJ GENAZZANI AR LOWRY PJ PETRAGLIA F
Citation: P. Florio et al., CHANGES IN AMNIOTIC-FLUID IMMUNOREACTIVE CORTICOTROPIN-RELEASING FACTOR (CRF) AND CRF-BINDING PROTEIN-LEVELS IN PREGNANT-WOMEN AT TERM AND DURING LABOR, The Journal of clinical endocrinology and metabolism, 82(3), 1997, pp. 835-838
BODY-WEIGHT, BODY-FAT DISTRIBUTION, AND HORMONAL REPLACEMENT THERAPY IN EARLY POSTMENOPAUSAL WOMEN
Authors: GAMBACCIANI M CIAPONI M CAPPAGLI B PIAGGESI L DESIMONE L ORLANDI R GENAZZANI AR
Citation: M. Gambacciani et al., BODY-WEIGHT, BODY-FAT DISTRIBUTION, AND HORMONAL REPLACEMENT THERAPY IN EARLY POSTMENOPAUSAL WOMEN, The Journal of clinical endocrinology and metabolism, 82(2), 1997, pp. 414-417
BODY-WEIGHT, BODY-FAT DISTRIBUTION, AND HORMONAL REPLACEMENT THERAPY IN EARLY POSTMENOPAUSAL WOMEN (VOL 82, PG 414, 1997)
Authors: GAMBACCIANI M CIAPONI M CAPPAGLI B PIAGGESI L DESIMONE L ORLANDI R GENAZZANI AR
Citation: M. Gambacciani et al., BODY-WEIGHT, BODY-FAT DISTRIBUTION, AND HORMONAL REPLACEMENT THERAPY IN EARLY POSTMENOPAUSAL WOMEN (VOL 82, PG 414, 1997), The Journal of clinical endocrinology and metabolism, 82(12), 1997, pp. 4074-4074
A LONG-TERM TREATMENT WITH GONADOTROPIN-RELEASING-HORMONE AGONIST PLUS A LOW-DOSE ORAL-CONTRACEPTIVE IMPROVES THE RECOVERY OF THE OVULATORYFUNCTION IN PATIENTS WITH POLYCYSTIC-OVARY-SYNDROME
Authors: GENAZZANI AD PETRAGLIA F BATTAGLIA C GAMBA O VOLPE A GENAZZANI AR
Citation: Ad. Genazzani et al., A LONG-TERM TREATMENT WITH GONADOTROPIN-RELEASING-HORMONE AGONIST PLUS A LOW-DOSE ORAL-CONTRACEPTIVE IMPROVES THE RECOVERY OF THE OVULATORYFUNCTION IN PATIENTS WITH POLYCYSTIC-OVARY-SYNDROME, Fertility and sterility, 67(3), 1997, pp. 463-468
AN INCREASED VULNERABILITY TO STRESS IS ASSOCIATED WITH A POOR OUTCOME OF IN-VITRO FERTILIZATION-EMBRYO TRANSFER TREATMENT
Authors: FACCHINETTI F MATTEO ML ARTINI GP VOLPE A GENAZZANI AR
Citation: F. Facchinetti et al., AN INCREASED VULNERABILITY TO STRESS IS ASSOCIATED WITH A POOR OUTCOME OF IN-VITRO FERTILIZATION-EMBRYO TRANSFER TREATMENT, Fertility and sterility, 67(2), 1997, pp. 309-314
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>